Fundraising Fox

Erika Kjellberg Eriksson

Investor

CEO and Chair of the Board at NXT2B

Greater Uppsala Metropolitan Area

About

Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.

Contact· self-published, not guessed

Experience

  1. CRB Inverbío SGEICPresidentcurrent2001 — presentMadrid Area, Spain

Skills & more

Science7Biotechnology21Healthcare12Venture Capital24Entrepreneurship6Medicine6R&D3Start-ups8Technology Transfer3Research and Development (R&D)1Strategy16Spanish9

From Erika's professional profile.

Deals · 9

AllgoHolding ABSolo GP

via NXT2B

Hansa Biopharma ABSolo GP

via NXT2B

Lokon Pharma ABSolo GP

via NXT2B

Lumina Adhesives ABSolo GP

via NXT2B

Navinci Diagnostics ABSolo GP

via NXT2B

Q-linea ABSolo GP

via NXT2B

Repos Pharma ABSolo GP

via NXT2B

Scint-X ABSolo GP

via NXT2B

Vivolux ABSolo GP

via NXT2B

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Colleagues at NXT2B

Frequently asked questions

Who is Erika Kjellberg Eriksson?
Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.
Where does Erika Kjellberg Eriksson work?
Erika Kjellberg Eriksson is CEO and Chair of the Board at NXT2B.
Where did Erika Kjellberg Eriksson go to school?
Erika Kjellberg Eriksson studied at Harvard University (Master in Public Health and Master in Health Policy and Management); Universidad Autónoma de Madrid (Economics); Universidad Complutense de Madrid (Medicine and Surgery).

Same school